|
MRI News Service:
'Gadolinium' p6 |
|
|
|
 |
 | | | ''In response to concern over gadolinium-based contrast agents, Little Company of Mary, a not-for-profit Catholic community hospital in Evergreen Park, Ill., wanted to provide the highest quality and safest MRA procedures to its patients. To accomplish ...' | | Thursday, 25 February 2010 by medical.toshiba.com |
|
|
|
| | | ''Addition of the contrast agent gadolinium during magnetic resonance imaging (MRI) for primary tumor assessment improved accuracy for detecting lymph node metastases, according to a new study published online February 1 in the Journal of the National ...' | | | Monday, 1 February 2010 by www.sciencedaily.com | |
|
|
|
| | | ''Acute adverse reactions from gadolinium-based contrast agents used during magnetic resonance imaging (MRI) to help improve the information seen on the images rarely occur, according to a study published in the February issue of the American Journal of ...' | | | Wednesday, 20 January 2010 by www.healthcanal.com | |
|
|
|
| | | ''GE Healthcare has promoted a vigorous scientific debate about the safety of Gadolinium Based Contrast Agents (GBCAs), including Omniscan™ and we reject any suggestion to the contrary. Like the many other scientists who have contributed to this ...' | | | Sunday, 20 December 2009 by newsroom.gehealthcare.com | |
|
|
|
| | | ''The US Drug Watchdog is launching a national investigation into the Gadolinium based dye used in MRI imaging, out of fear that thousands of US citizens with kidney disease, who had an MRI or other scan with contrast, may now have an incurable medical ...' | | | Monday, 14 December 2009 by www.earthtimes.org | |
|
|
|
| | | ''The European Medicines Agency (EMEA) has adopted a set of recommendations aimed at minimising the risk of nephrogenic systemic fibrosis (NSF) with gadolinium-containing contrast agents in patients at risk of developing the ...' | | | Friday, 20 November 2009 by www.ema.europa.eu | |
|
|
|
| | | ''Drug and medical device company Covidien said Nov. 9 that it is changing the label of its imaging agent Optimark to indicate that it is dangerous for use in patients with severe renal impairment. Optimark gadoversetamide injection is a ...' | | | Wednesday, 11 November 2009 by www.renalbusiness.com | |
|
|
|
| | | ''The committees will discuss safety considerations related to FDA approved gadolinium-based contrast agents used with magnetic resonance imaging (MRI) scans. An MRI is a medical imaging technique that does not require x-rays. These scans outline the ...' | | | Thursday, 15 October 2009 by www.fda.gov | |
|
|
|
| | | ''Using a set of three biocompatible polymers and a nanoparticle containing gadolinium, a team of investigators at the Colorado School of Mines has created a nanoparticle platform that has the potential to target, image, and treat cancer. Gadolinium ...' | | | Monday, 27 April 2009 by www.news-medical.net | |
|
|
|
| | | ''Since December 2006, FDA has continued to investigate reports of nephrogenic systemic fibrosis (NSF) in patients who received gadolinium-based contrast agents (GBCAs) to help define risk factors for NSF. In addition, the FDA has requested the ...' | | | Friday, 9 January 2009 by www.fda.gov | |
|
|
|
|
|
|
|
|
| Result Pages |
|
|
|
|
|
Wine makes a man more pleased with himself; I do not say that it makes him
more pleasing to others.
- Samuel Johnson |
|
|
News
top
